Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer

Published:2013-08 Issue:2 Volume:55 Page:305-308
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Milat F.,Goh S.,Gani L.U.,Suriadi C.,Gillespie M.T.,Fuller P.J.,Teede H.J.,Strickland A.H.,Allan C.A.

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference14 articles.

1. Denosumab: a new option in the treatment of bone metastases from urological cancers;Yuasa;Onco Targets Ther,2012

2. Cancer to bone: a fatal attraction;Weilbaecher;Nat Rev Cancer,2011

3. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study;Fizazi;Lancet,2011

4. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma;Saad;J Natl Cancer Inst,2002

5. Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials;Lipton;Eur J Cancer,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External Validation and Update of the Risk Prediction Model for Denosumab-Induced Hypocalcemia Developed From a Hospital-Based Administrative Database;JCO Clinical Cancer Informatics;2024-07

2. Hungry bone syndrome like presentation following single-dose denosumab for hypercalcaemia secondary to sarcoidosis with IgA nephropathy;BMJ Case Reports;2022-07

3. A Case of Recurrent Severe Hypocalcemia with Prolonged Hospitalization and Readmissions After Single Dose of Denosumab in Metastatic Prostate Cancer Patient;Journal of Community Hospital Internal Medicine Perspectives;2022-04-11

4. Denosumab-associated hypocalcemia: Does gender play a role?;Maturitas;2020-12

5. Hypocalcaemia following denosumab in prostate cancer: A clinical review;Clinical Endocrinology;2020-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3